人际心理和认知行为分别联合度洛西汀治疗躯体形式障碍的效果对比

Effect comparison of interpersonal psycholocy and cognitive behavior combined with Duloxetine in the treatment of somatoform disorders

目的分析人际心理(TPT)和认知行为(CBT)分别联合度洛西汀治疗躯体形式障碍的效果。方法选取2016年1月~2018年12月我院治疗的99例躯体形式障碍患者,按照随机数字表法分为Ⅰ、Ⅱ、Ⅲ组,每各组33例。Ⅰ组给予TPT联合度洛西汀治疗,Ⅱ组给予CBT联合度洛西汀治疗,Ⅲ组给予单纯的度洛西汀治疗;比较三组的总有效率、汉密尔顿焦虑量表(HAMA)评分、汉密尔顿抑郁量表(HAMD)评分、躯体化症状自评量表(SCL-90)评分。结果Ⅰ组与Ⅱ组的治疗总有效率比较,差异无统计学意义(P>0.05),且均高于Ⅲ组(P<0.05);Ⅰ组与Ⅱ组治疗后的HAMA、HAMD、SCL-90评分比较,差异无统计学意义(P>0.05),且均低于Ⅲ组(P<0.05)。结论TPT和CBT分别联合度洛西汀治疗躯体形式障碍,均能有效提高治疗效果,改善患者的病情,促进患者痊愈,临床应根据患者的实际情况选择治疗方式。

Objective To analysis of the effects of interpersonal psycholocy and cognitive behavioral therapy combined with Duloxetine in the treatment of somatoform disorders. Methods A total of 99 cases of somatoform disorders who treated in our hospital from January 2016 to February 2018 were selected and randomly divided into groupⅠ,Ⅱ,Ⅲ according to random number table method, 33 cases in each group. Group Ⅰ was given interpersonal psychotherapy combined with Duloxetine, group Ⅱ was given cognitive behavioral therapy combined with Duloxetine, and group Ⅲ was given Duloxetine alone. The total effectiveness of the three groups, the Hamilton anxiety scale (HAMA) score, the Hamilton depression rating scale (HAMD) score, and the Somaticization scale (SCL-90) score were compared the three groups. Resules There was no significant difference in the total effective rate between group Ⅰand group Ⅱ(P>0.05), and the total effective rate was higher than that in group Ⅲ(P<0.05). There was no significant difference after treatment HAMA, HAMD and SCL-90 scores between group Ⅰ and group Ⅱ(P>0.05), and they were lower than those of group Ⅲ(P<0.05). Conclusion TPT and CBT combined with Duloxetine for the treatment of somatoform disorders, can effectively improve the treatment effect, improve the patient′s condition, promote the recovery of patients, clinically should choose the treatment according to the actual situation of the patient.